Inozyme Pharma Inc (INZY) Directors and Executive Officers - CSIMarket
CSIMarket
 
Inozyme Pharma Inc   (NASDAQ: INZY)

Inozyme Pharma Inc

Officers & Directors


1. Douglas A. Treco
Chief Executive Officer and Chairman

2. Lynne Sullivan
Director

3. Robert Hopfner
Director

4. Sanjay Subramanian
Chief Financial Officer

5. Axel Bolte
Director

6. Reinaldo Diaz
Director

7. Edward Mathers
Director

8. Martin Edwards
Director

9. Sarah Bhagat
Director ,

Inozyme Pharma Inc currently has 67 employees.

  News about Inozyme Pharma Inc Key Personnel

Navigating Rare Discoveries and Financial Recoveries: The Journey of Inozyme Pharma



Inozyme Pharma, a clinical-stage rare disease biopharmaceutical company, recently announced the granting of stock options to three new employees as part of its ongoing efforts to develop novel therapeutics for pathologic mineralization and intimal proliferation. This move comes amid the company s financial struggles, as revealed by its cumulative net loss of $-68 million during the 12 months ending in the third quarter of 2023. With a negative return on assets (ROA) of -42.76%, Inozyme Pharma faces significant challenges within the healthcare sector.
The company s financial performance is cause for concern, particularly when compared to other entities within the healthcare sector. During the sa...






INZY Management Effectiveness INZY Revenue per Employee INZY Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.